CD40LG and COVID-19: In this study, we developed and validated a multiplex serological tool based on the Luminex xMAP® technology, evaluated its performance against 4 antigens (S1, S2, RBD and N) for the detection of SARS-CoV-2 specific IgM and IgG antibodies in a cohort of COVID-19 confirmed patients.